Skip to main content
Pharmsville Co., Ltd. logo

Pharmsville Co., Ltd. — Investor Relations & Filings

Ticker · 318010 ISIN · KR7318010006 KO Manufacturing
Open in API
Filings indexed 129 across all filing types
Latest filing 2025-05-02 Director's Dealing
Country KR South Korea
Listing KO 318010

About Pharmsville Co., Ltd.

http://pharmsville.net/

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a mandatory disclosure for insiders (directors, executives, and major shareholders) to report changes in their shareholdings, commonly referred to as 'Director's Dealing' or 'Insider Trading' reports in international financial terminology. Given the specific nature of reporting personal share transactions by major shareholders and executives, it falls under the 'DIRS' category.
2025-05-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership by major shareholders (Lee Byung-wook and related parties) of the company 'Pharmsville'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant changes in ownership levels that cross regulatory reporting thresholds.
2025-05-02 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 거래계획보고서) filed with the Financial Supervisory Service (증권선물위원회) and the Korea Exchange. It details a specific plan by an executive (Lee Byung-wook) to transfer shares (gift) of Pharmsville. This falls under the category of director/insider dealing and trading plans, which is classified as 'Director's Dealing' (DIRS) in the provided schema.
2025-04-02 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 거래계획보고서) filed with the Securities and Futures Commission and the Korea Exchange. This document details the planned acquisition of shares by a major shareholder (Health Click) of Pharmsville. In the context of financial filings, reports regarding insider trading plans or changes in shareholdings by major shareholders are classified under 'Director's Dealing' (DIRS) as they pertain to insider transactions and ownership disclosures.
2025-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal report titled '정기주주총회결과' (Annual General Meeting Results) dated 2025-03-28. It details the outcomes of the meeting, including the approval of financial statements, dividend declarations, and the election of directors. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it provides the official results of shareholder votes at an AGM.
2025-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of new outside directors for the company 'Pharmsville'. This falls under the category of Board/Management Information, specifically regarding changes in the board of directors.
2025-03-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.